Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
MUNICH, Germany, Nov. 02, 2021 (GLOBE NEWSWIRE) -- HMNC Brain Health (“HMNC” or the “company”), a clinical stage biopharma company pioneering the development of personalized therapies powered by...
-
MUNICH, Nov. 01, 2021 (GLOBE NEWSWIRE) -- HMNC Brain Health ("HMNC" or the "company"), a clinical-stage biopharma company pioneering the development of personalized therapies powered by predictive...
-
Pioneering the first large-scale double-blind studies to test the combination of therapies and genetic companion diagnostics in the area of mental healthPartners with worldwide leading contract...
-
MUNICH, Germany, Sept. 07, 2021 (GLOBE NEWSWIRE) -- HMNC Brain Health (“HMNC” or the “company”), a clinical stage biopharma company pioneering the development of personalized therapies powered by...
-
MUNICH, Germany, Aug. 24, 2021 (GLOBE NEWSWIRE) -- HMNC Brain Health (“HMNC” or the “company”), a clinical stage biopharma company pioneering the development of personalized therapies powered by...
-
MUNICH, Germany, July 28, 2021 (GLOBE NEWSWIRE) -- HMNC Brain Health (“HMNC” or the “Company”), a biotech company pioneering the development of personalized therapies in psychiatry powered by...